uniQure (QURE) Reports Q2 Loss, Misses Revenue Estimates

uniQure (QURE) came out with a quarterly loss of $0.69 per share versus the Zacks Consensus Estimate of a loss of$ 0.89. This compares to a loss of $1.16 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +22.47%. A quarter ago, it was expected that this human gene therapy company would post a loss of$ 1.07 per share when it actually produced a loss of $0.82, delivering a surprise of +23.36%.Over the last four quarters, the compa ...